Stifel Maintains Hold on Iridex, Maintains $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Thomas Stephan maintains a Hold rating on Iridex (NASDAQ:IRIX) with a $2 price target.
May 15, 2024 | 11:49 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel analyst Thomas Stephan has reiterated a Hold rating on Iridex (NASDAQ:IRIX) and maintained a $2 price target.
The Hold rating and maintained price target suggest that the analyst does not foresee significant short-term movement in the stock price. This neutral stance indicates that investors should not expect major changes in the stock's performance based on this rating alone.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100